bioAffinity Technologies (BIAF) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Precipio is the larger company by market cap ($41.4 million vs $5.5 million), about 7.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | PRPO |
|---|---|---|
| Share price | $4.73 | $23.12 |
| Market cap | $5.51M | $41.39M |
| 1-day change | -16.22% | -0.30% |
| YTD return | — | +0.61% |
| 1-year return | — | +17.60% |
| 5-year return | — | -54.84% |
| Forward P/E | — | 59.28 |
| EPS (TTM) | $-109.35 | $-0.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $80.70 | $33.63 |
| 52-week low | $4.56 | $16.40 |
| Distance from 52-week high | -94.14% | -31.25% |
| Average volume | 3.73M | 127.60K |
| Shares outstanding | 1.17M | 1.79M |
| Employees | 57 | 61 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Precipio is about 7.5 times larger than bioAffinity Technologies by market value ($41.39M vs $5.51M).
- The two companies sit in different sectors: bioAffinity Technologies in Health Care and Precipio in Industrials.
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About Precipio
PRPO stock →Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 61 employees
BIAF vs PRPO FAQ
Which is bigger, bioAffinity Technologies or Precipio?
Precipio (PRPO) is larger, with a market capitalization of $41.39M compared with $5.51M for bioAffinity Technologies (BIAF).
Are bioAffinity Technologies and Precipio in the same industry?
No. bioAffinity Technologies is in the Health Care sector, while Precipio is in Industrials.